Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stimulants01:29

Stimulants

1.3K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.3K
Drug Dependence01:17

Drug Dependence

2.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
2.0K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

2.3K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.3K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.6K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.6K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

564
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
564

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Child and maternal health outcomes following antenatal exposure to classic psychedelic substances: a systematic review.

Research square·2026
Same author

Advancing the Field of Psychedelic Epidemiology.

Psychedelic medicine (New Rochelle, N.Y.)·2026
Same author

Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial.

JAMA network open·2026
Same author

Acute effects of electronic nicotine delivery system liquid nicotine form and sweet enhancer among people who use inhaled tobacco products.

Experimental and clinical psychopharmacology·2026
Same author

Safety and tolerability of electronic cigarettes to reduce cigarette smoking: Secondary analysis from a randomized placebo-controlled trial.

medRxiv : the preprint server for health sciences·2026
Same author

Psilocybin or Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical Trial.

JAMA network open·2026
Same journal

Factors influencing the trustworthiness of non-randomized studies of interventions: a survey of international experts.

BMC medicine·2026
Same journal

Structural-functional network decoupling in early stage amyotrophic lateral sclerosis reveals cell-type specific transcriptional signatures.

BMC medicine·2026
Same journal

A lesion-derived brain network of somatic symptoms for transdiagnostic individual application.

BMC medicine·2026
Same journal

Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 study.

BMC medicine·2026
Same journal

Adverse and positive childhood experiences and suicidal ideation onset in a US pre-early adolescent cohort.

BMC medicine·2026
Same journal

Dual-drug-loaded nanohydrogel for intraoperative local application: sequential release-mediated spatiotemporal targeting of diverse secondary injury mechanisms to improve long-term prognosis in traumatic brain injury.

BMC medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 12, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.8K

Electronic cigarettes and nicotine dependence: evolving products, evolving problems.

Caroline O Cobb1, Peter S Hendricks2, Thomas Eissenberg3

  • 1Department of Psychology, Center for the Study of Tobacco Products, Virginia Commonwealth University, 1112 East Clay Street, Suite B-08, Box 980205, Richmond, VA, 23298, USA. cobbco@vcu.edu.

BMC Medicine
|May 23, 2015
PubMed
Summary
This summary is machine-generated.

Electronic cigarettes (ECIGs) pose risks due to nicotine delivery variability. Low-nicotine ECIGs may not reduce smoking risks, while high-nicotine versions can increase dependence, complicating cessation for all users.

More Related Videos

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

12.3K
A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

9.1K

Related Experiment Videos

Last Updated: Apr 12, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.8K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

12.3K
A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

9.1K

Area of Science:

  • Public Health
  • Nicotine Science
  • Addiction Research

Background:

  • Electronic cigarettes (ECIGs) aerosolize liquids containing nicotine, propylene glycol, vegetable glycerin, and flavorants.
  • Nicotine dependence from ECIG use is a growing public health concern.
  • Nicotine delivery varies significantly across different ECIG products.

Purpose of the Study:

  • To examine the implications of nicotine delivery variability in ECIGs for smokers and non-smokers.
  • To assess the potential for ECIGs to substitute for tobacco cigarettes or lead to new nicotine dependence.
  • To inform regulatory strategies for mitigating population-level nicotine dependence.

Main Methods:

  • Review of existing literature on ECIG nicotine delivery profiles.
  • Analysis of potential health outcomes associated with varying nicotine concentrations in ECIGs.
  • Assessment of risks for initiating nicotine use and developing dependence in different user groups.

Main Results:

  • Some ECIGs deliver substantially less nicotine than tobacco cigarettes, potentially limiting harm reduction benefits.
  • Other ECIGs may deliver nicotine at levels exceeding tobacco cigarettes, increasing dependence and complicating cessation.
  • Variability poses risks for non-smokers, potentially leading to nicotine initiation and progression to higher doses or other products.

Conclusions:

  • The wide range of nicotine delivery from ECIGs presents complex challenges for public health.
  • ECIGs may not effectively substitute for tobacco cigarettes, and can lead to new or increased nicotine dependence.
  • Evidence-based regulatory action is necessary to manage population-level nicotine dependence risks associated with ECIGs.